These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 427816)

  • 1. Estrogen and progesterone receptors in human breast cancer with concomitant assay of plasma 17beta-estradiol, progesterone, and prolactin levels.
    Nagai R; Kataoka M; Kobayashi S; Ishihara K; Tobioka N; Nakashima K; Naruse M; Saito K; Sakuma S
    Cancer Res; 1979 May; 39(5):1834-40. PubMed ID: 427816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved measurement of androgen receptors in human breast cancer.
    Lea OA; Kvinnsland S; Thorsen T
    Cancer Res; 1989 Dec; 49(24 Pt 1):7162-7. PubMed ID: 2582456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Content of 17 beta éstradiol, progesterone and glucocorticoid receptors in patients with benign breast diseases].
    Bassalyk LS; Kuz'mina ZV; Murav'eva NI; Smirnova KD; Vishniakova VV
    Vopr Onkol; 1982; 28(7):3-6. PubMed ID: 7101825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
    Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
    J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and assay of progesterone receptor in human mammary carcinoma.
    Pichon MF; Milgrom E
    Cancer Res; 1977 Feb; 37(2):464-71. PubMed ID: 832270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma prolactin concentrations and risk of postmenopausal breast cancer.
    Tworoger SS; Eliassen AH; Rosner B; Sluss P; Hankinson SE
    Cancer Res; 2004 Sep; 64(18):6814-9. PubMed ID: 15375001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hormone receptors and breast cancer prognosis].
    Saez S; Pichon MF
    Pathol Biol (Paris); 1983 Dec; 31(10):801-8. PubMed ID: 6366701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histochemical studies with an estrogen receptor-related protein in human breast tumors.
    Cano A; Coffer AI; Adatia R; Millis RR; Rubens RD; King RJ
    Cancer Res; 1986 Dec; 46(12 Pt 1):6475-80. PubMed ID: 3536082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of an immunocytochemical assay for progesterone receptor with a biochemical method of measurement and immunocytochemical examination of the relationship between progesterone and estrogen receptors.
    Berger U; Wilson P; Thethi S; McClelland RA; Greene GL; Coombes RC
    Cancer Res; 1989 Sep; 49(18):5176-9. PubMed ID: 2766287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estradiol receptor levels in human breast carcinomas.
    Bird CE; Houghton B; Westenbrink W; Tenniswood M; Sterns EE; Clark AF
    Can Med Assoc J; 1981 Apr; 124(8):1010-2. PubMed ID: 7260784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of estrogen, progesterone and prolactin receptors in human breast cancer.
    Calandra RS; Charreau EH; Royer de Giaroli M; Baldi A
    Prog Clin Biol Res; 1984; 142():97-108. PubMed ID: 6709661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Progesterone receptors in breast cancer].
    Vitola GIa; Zeĭkate GA; Grabovska IK
    Vopr Onkol; 1987; 33(9):35-8. PubMed ID: 3660754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytoplasmic steroid hormone receptors in primary breast tumors].
    Bassalyk LS; Murav'eva NI; Smirnova KD; Kuz'mina ZV; Vishniakova VV
    Vopr Onkol; 1982; 28(4):6-10. PubMed ID: 7090272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroid receptor analyses of nine human breast cancer cell lines.
    Horwitz KB; Zava DT; Thilagar AK; Jensen EM; McGuire WL
    Cancer Res; 1978 Aug; 38(8):2434-7. PubMed ID: 667841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of cytosolic receptors for estradiol and progesterone in 137 cases of breast cancer: technics, clinical and histopathological correlations].
    Dewailly D; Bonneterre J; Vandewalle B; Delobelle A; Lefebvre J; Demaille AC
    Lille Med; 1980 Nov; 25(9):496-501. PubMed ID: 7453486
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of estrogen and progesterone receptors and the dissociated regulation of growth and progesterone receptor stimulation by estrogen in MDA-MB-134 human breast cancer cells.
    Reiner GC; Katzenellenbogen BS
    Cancer Res; 1986 Mar; 46(3):1124-31. PubMed ID: 3943090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between PRL levels and steroid receptors in breast cancer.
    Marugo M; Fazzuoli L; Bernasconi D; Berta S; Giordano G
    Anticancer Res; 1988; 8(4):819-23. PubMed ID: 3178171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the gene encoding a prolactin-inducible protein by human breast cancers in vivo: correlation with steroid receptor status.
    Murphy LC; Lee-Wing M; Goldenberg GJ; Shiu RP
    Cancer Res; 1987 Aug; 47(15):4160-4. PubMed ID: 3607757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Steroid hormone receptors and survival in breast cancer patients].
    Ivanova OA; Tsyrlina EV; Moiseenko VM; Semiglazov VF
    Vopr Onkol; 1986; 32(6):71-6. PubMed ID: 3727485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histochemical determination of estrogen and progesterone binding in fine needle aspirates of breast cancer. Correlation with conventional biochemical assays.
    Curtin CT; Pertschuk LP; Mitchell V
    Acta Cytol; 1982; 26(6):841-6. PubMed ID: 6961721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.